Pholedrine

Pholedrine

SCHEMBL119262

CNC(C)Cc1ccc(O)cc1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 5/20 0.63
SIGMAR1 Q99720 2/20 0.63
SLC18A2 Q05940 1/20 0.63
SLC6A4 P31645 3/20 0.60
SLC6A2 P23975 2/20 0.57
ESR1 P03372 1/20 0.55
ESR2 Q92731 1/20 0.55
ADRB2 P07550 5/20 0.51
CYP3A4 P08684 2/20 0.51
MAPK1 P28482 2/20 0.51
CYP2D6 P10635 1/20 0.51
TSHR P16473 1/20 0.51
HIF1A Q16665 1/20 0.51
HSD17B10 Q99714 1/20 0.51
ADRB1 P08588 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
ADRB3 P13945 1/20 0.51
PTGS1 P23219 1/20 0.51
HTR2A P28223 1/20 0.51
MC4R P32245 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pholedrine SCHEMBL2739157 1.00 TAAR1 (0.63) TAAR1SIGMAR1SLC18A2SLC6A4SLC6A2
Pholedrine SCHEMBL15286090 1.00 TAAR1 (0.63) TAAR1SIGMAR1SLC18A2SLC6A4SLC6A2
Pholedrine SCHEMBL1649743 0.91 TAAR1 (0.53) TAAR1SIGMAR1SLC18A2SLC6A4SLC6A2
Pholedrine SCHEMBL317510 0.91 TAAR1 (0.53) TAAR1SIGMAR1SLC18A2SLC6A4SLC6A2
SCHEMBL2958028 0.83 SLC6A4 (0.63) TAAR1SIGMAR1SLC6A4SLC6A2ESR1
SCHEMBL15133588 0.81 HTR1B (0.54) TAAR1SIGMAR1SLC18A2SLC6A4SLC6A2
SCHEMBL12907812 0.81 TAAR1 (0.55) TAAR1SIGMAR1SLC6A4SLC6A2ESR1
SCHEMBL13996943 0.81 CYP2D6 (0.66) TAAR1SIGMAR1SLC6A4SLC6A2ESR1
SCHEMBL765297 0.80 TAAR1 (0.65) TAAR1SIGMAR1SLC18A2SLC6A4SLC6A2
SCHEMBL178625 0.80 TAAR1 (0.65) TAAR1SIGMAR1SLC18A2SLC6A4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5125 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137082-A1 FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL SYNGENTA CROP PROTECTION AG (CH) 2026-05-21 US claimed
EP-4722714-A1 SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) Korea Institute of Science and Technology (KR) 2026-04-08 EP claimed
WO-2025244856-A1 METHODS AND COMPOSITIONS RELATING TO ELQ COMPOUNDS OREGON HEALTH & SCIENCE UNIVERSITY (US) 2025-11-27 WO claimed
EP-3060043-B1 PESTICIDAL COMPOSITIONS AND RELATED METHODS CORTEVA AGRISCIENCE LLC (US) 2025-11-26 EP claimed
US-12471599-B2 Agricultural compositions comprising remodeled nitrogen fixing microbes PIVOT BIO, INC. (US) 2025-11-18 US claimed
EP-3578542-B1 COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-11-12 EP claimed
EP-4627920-A1 BINARY INSECTICIDE COMPOSITION AND USE THEREOF Shenyang Sinochem Agrochemicals R & D Co., Ltd. (CN) 2025-10-08 EP claimed
EP-3578543-B1 COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-08-20 EP claimed
US-20250185667-A1 AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBES HSBC BANK USA, N.A. 2025-06-12 US claimed
EP-3578541-B1 COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-05-28 EP claimed
EP-1134290-A2 Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors Pfizer Products Inc. (US) 2001-09-19 EP claimed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed
US-5858410-A Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (DE) 1999-01-12 US claimed
EP-0311383-B1 MONOCLONAL ANTIBODY TO METHAMPHETAMINE, PREPARATION OF THE SAME, ASSAY METHOD AND ASSAY KIT OF METHAMPHETAMINE UBE INDUSTRIES, LTD. (JP) 1993-10-06 EP claimed
EP-0046270-B1 NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM INTERx RESEARCH CORPORATION (US) 1986-05-21 EP claimed
EP-0046270-A1 Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them INTERx RESEARCH CORPORATION (US) 1982-02-24 EP claimed
EP-0006212-B1 SYSTEM OF PULVERISATION IN THE FORM OF AN AEROSOL Airwick AG (CH) 1981-08-05 EP claimed
EP-0006212-A1 System of pulverisation in the form of an aerosol Airwick AG (CH) 1980-01-09 EP claimed